BioHarvest Sciences Total Current Liabilities 2020-2024 | BHST
BioHarvest Sciences total current liabilities from 2020 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
BioHarvest Sciences Annual Total Current Liabilities (Millions of US $) |
2023 |
$26 |
2022 |
$12 |
2021 |
$3 |
2020 |
$2 |
2019 |
$26 |
2019 |
$0 |
2018 |
$0 |
BioHarvest Sciences Quarterly Total Current Liabilities (Millions of US $) |
2024-06-30 |
$9 |
2024-03-31 |
$13 |
2023-12-31 |
$26 |
2023-09-30 |
$15 |
2023-06-30 |
$13 |
2023-03-31 |
$10 |
2022-12-31 |
$12 |
2022-09-30 |
$9 |
2022-06-30 |
$5 |
2022-03-31 |
$2 |
2021-12-31 |
$3 |
2021-09-30 |
$2 |
2021-06-30 |
$2 |
2021-03-31 |
$7 |
2020-12-31 |
$2 |
2020-09-30 |
$1 |
2020-06-30 |
$2 |
2020-03-31 |
|
2019-12-31 |
|
2019-09-30 |
|
2019-06-30 |
|
2019-03-31 |
$0 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|